Monday, December 01, 2008
 
 
  Home arrow Abortion arrow Incest, Rape, Congenital Abnormalities arrow Mifepristone (RU 486)
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note
"We recommend that physicians should routinely inquire about the outcome of all the patient's pregnancies. The simple question, 'Have you experienced any pregnancy losses such as miscarriage, abortion, adoption, or stillbirth?' may be sufficient to give women permission to discuss unresolved issues related to prior pregnancy losses. Physicians should remember that there are few social contexts in which women feel it is appropriate to discuss unresolved feelings about prior pregnancy loss. Many patients will appreciate the opportunity to discuss their pregnancy losses with an empathetic person and may welcome referrals for additional counseling." David Reardon, Ph.D.
 
Mifepristone (RU 486) PDF Print E-mail

The proposed RU-486 Suspension and Review Act of 2003 would suspend use of the drug until a complete investigation of the approval process has been completed. The bill has been introduced in the House (HR 3453) and Senate (S 1930).

The bill is the result of concerns expressed by the family of Holly Patterson after her untimely death following an RU-486 abortion. Go to Library of Congress at http://thomas.loc.gov and search by bill number. [communiqué 12Dec03; ple-news 16Dec03]

 
< Prev   Next >


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2008 All Rights Reserved